Клиническая база Оксфорда стала полноправным участником национальной сети исследований болезни Альцгеймера

Oxford Health has been named a full member of the National Institute for Health and Care Research (NIHR) UK Dementia Trials Network. The network is a national initiative designed to improve the delivery of early-phase dementia clinical trials. Oxford Health is now one of just nine full member sites across the country. Amanda Colston, NIHR Clinical Research Facility matron at Oxford Health, said: "Becoming a full member of the UK Dementia Trials Network is a significant achievement for Oxford Health and a testament to the expertise of our clinical and research teams. Read more Maigret star answers if Rowan Atkinson ITV crime drama will return 'Significant disruption' as Oxfordshire road bridge closing for 10 weeks 80s singing legend helps open new £1.9m MRI scanner at hospital "Dementia is one of the greatest health challenges of our time. "Through the UKDTN, we can work with partners across the country to bring innovative trials to our patients, widen participation and help accelerate the development of better treatments and care." The UKDTN brings together NHS organisations, universities, industry partners, charities, and people with lived experience of dementia. Its goal is to make the UK a leading destination for high-quality research studies by improving the speed, consistency, and inclusivity of trial delivery. Despite nearly one million people in the UK living with dementia, less than one per cent currently take part in early-stage clinical trials. The network aims to change this by building specialist infrastructure, developing expert teams, and placing dedicated Dementia Research Nurses within NHS organisations. These nurses support participants and their families, helping to improve access to and experience of research. Oxford Health’s new status reflects its strong research portfolio, close academic partnerships, and commitment to patient-centred, inclusive studies. The trust will now help shape the future of dementia trials and attract cutting-edge research to the region. Samuel Agyapong, Alzheimer’s Society UKDTN senior research nurse based at Oxford Health’s clinical research facility, said: "It is a real privilege to join experienced nurses across the country as part of the first UK-wide network of dementia research nurses. "For me, this role is deeply personal and meaningful because it creates the opportunity to focus my skills, passion and energy on delivering high-quality, compassionate and accessible research for people affected by dementia and their families. "Together with colleagues across the nurses’ network and at our CRF, I hope to reduce feelings of helplessness and build hope for families affected by dementia by supporting studies that are caring, inclusive and meaningful to their lives." For people in Oxfordshire and Buckinghamshire, membership in the UKDTN means greater access to innovative dementia studies closer to home. For the NHS, it strengthens efforts to deliver more equitable and impactful research. To find out more about taking part in dementia research at Oxford Health, email [email protected].